Sex specific effects of ketamine, but not other glutamate receptor modulators, on ethanol self-administration and reinstatement of ethanol seeking in rats.
Study Goal
The researchers aimed to determine the effects of ketamine (an NMDAR antagonist) on alcohol-motivated behaviors, including stress + cue-induced reinstatement of alcohol seeking, in male and female rats.
Results Summary
Ketamine selectively reduced alcohol self-administration and stress + cue-induced reinstatement in female rats but not males at 10 mg/kg. Memantine (another NMDAR antagonist) reduced alcohol seeking in both sexes, while hydroxynorketamine (HNK) had no effect.
Population
Male and female rats
Effective Dosage
10 mg/kg ketamine
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
ketamine | increase | treatment-resistant depression | individuals with treatment-resistant depression | - | has been shown to have rapid and long-lasting effects | #1 |
ketamine | decrease | drinking | individuals with alcohol use disorder | - | reduces drinking | #2 |
ketamine (10 mg/kg) | decrease | alcohol self-administration | female rats | - | selective reduction | #3 |
ketamine (10 mg/kg) | decrease | YOH + cue-induced reinstatement of alcohol seeking | female rats | - | selective reduction | #4 |
ketamine (10 mg/kg) | no change | alcohol self-administration | male rats | - | no reduction | #5 |
ketamine (10 mg/kg) | no change | YOH + cue-induced reinstatement of alcohol seeking | male rats | - | no reduction | #6 |
ketamine (10 mg/kg) | decrease | YOH + cue-induced reinstatement of saccharin seeking | both sexes (rats) | - | effective in reducing | #7 |
memantine | decrease | alcohol seeking | both sexes (rats) | - | effective in reducing | #8 |
hydroxynorketamine (HNK) | no change | alcohol seeking | both sexes (rats) | - | had no effects | #9 |
RATIONALE: Alcohol use and major depressive disorder are frequently comorbid, with individuals diagnosed with a substance use disorder being nearly three times as likely to have major depression. Poor treatment responses are found for both disorders and are further complicated when they co-occur, underscoring the need for better therapies. One potential candidate is ketamine, which has been shown to have rapid and long-lasting effects in individuals with treatment-resistant depression and, in some studies, reduces drinking in alcohol use disorder. However, though women are more likely to have this comorbidity, few studies have examined sex-specific effects of ketamine on alcohol drinking, nor have studies assessed the potential for ketamine to reduce reinstatement of alcohol seeking. OBJECTIVES: The primary goal of the present studies was to determine the effects of ketamine on alcohol-motivated behaviors in male and female rats, including in a model of stress + cue-induced reinstatement of alcohol seeking using yohimbine (YOH). RESULTS: We found a selective reduction in alcohol self-administration and YOH + cue-induced reinstatement in females, but not males at a dose of 10 mg/kg ketamine. However, the same dose of ketamine was effective in reducing YOH + cue-induced reinstatement of saccharin seeking in both sexes. In addition, a different NMDAR antagonist, memantine, was effective in reducing alcohol seeking in both sexes, while the ketamine metabolite hydroxynorketamine (HNK) had no effects. CONCLUSIONS: In summary, these data suggest that antagonism of NMDARs may be effective in reducing stress-related alcohol seeking, but that ketamine has unique properties that lead to female-specific effects on alcohol seeking.